drugset / Trial / NCT05950152

Efficacy, Safety and Tolerability Study of Meloxicam Injection in Subjects After Abdominal Surgery

NCT05950152

RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to determine the analgesic efficacy and safety of Meloxicam Injection in subjects undergoing abdominal surgery.

Timeline

Start
2023-07
Primary completion
2023-12
Completion
2024-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Meloxicam Small molecule 30 mg
Subject Meloxicam Small molecule 60 mg

Indications